Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2654)	1/7/2010 1:17:18 PM
From: Jibacoa	Read Replies (1) of 3722

RXII is up 11% with volume now close to 90Ks > 1/2 its ADV. bigcharts.marketwatch.com The move is apparently in anticipation of RXII presentation scheduled for Tuesday in Frisco at the Biotech Showcase Conference.<g> YHOO's "analysts consensus" have RXII as "buy" with a "target" of $15, but Thomson-Reuters has it as a "sell" based on its "metrics".<g> The stock isn't off from the longer term DT coming from the March 2008 H at $23.95 bigcharts.marketwatch.com RXII has strong research on RNAi, including potential treatments for inflammatory and metabolic diseases, such as obesity and obesity-related type 2 diabetes. Also on ALS. It was able to trim some its loss on the 3rdQ but the loss for the Yr is still expected around $1.12 vs. $1.09 in 2008 For 2010 the loss is expected around $0.95 RXII has negligent LTD but has been burning its cash at a good clip.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next